3ThurlimannB,HessD,KoberleD ,etal.Anastrozole (′Arim idex′)versustamoxifenasfirst linetherapyin postmenopausalwomenwithadvancedbreastcancer:resultsofthedouble blindcross overSAKKtrial21/95 asub studyoftheTARGET (Ta moxifenor′Arimidex′RandomizedGroupEfficacyandTolerabili ty)trial. Breast Cancer Research and Treatment . 2004
4ParidaensR,DirixL,LohrischC ,etal.Matureresultsofaran domizedphaseⅡmulticenterstudyofexemestaneversustamoxifenasfirst linehormonetherapyfor postmenopausalwomenwithmetastaticbreastcancer. Annals of Oncology . 2003
6Forward DP,Cheung KL,Jackson L,et al.Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer. British Journal of Cancer . 2004
7Bonneterre J,Buzdar A,Nabholtz JM,et al.Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer . 2001
8Port ER,Montgomery LL,Heerdt AS,et al.Patient reluctance toward tamoxifen use for breast cancer primary prevention. Annals of Surgical Oncology . 2001
9Boccardo F,Rubagotti A,Amoroso D,et al.Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study. Journal of Clinical Oncology . 2001
10RoseC.A comparison of the efficacy of aromatase inhibitors in secondline treatment of metastatic breast cancer. American Journal of Clinical Oncology . 2003
2Hamilton A, piccart M. The third - generation non - steroidal aromatase inhibitors : a review of their clinical benefits in the second - line hormonal treatment of advanced breast cancer [J]. Anals of Oncology, 1999,10 (4) :377 - 384.
3Early Breast Cancer Trialists Collaborative Group. Tamoxifen for early breast cancer:an overview of the randomized trials [J].Lancet, 1998. 351 : 1451.
7Campos SM. Aromatase inhibitors for breast cancer in postmenopausal women [ J ]. Oncologist ,2004,9 (2) : 126 - 136.
8Howell A, Cuzick J, Baum M, et al. Results of the ATAC ( Arimidex, Tamoxifen, alone or in combination) trial after completion of 5 years'adjuvant treatment for breast cancer[ J]. Lancet,2005, 365:60 -62.
9Jakesz R, Jonat W, Gnant M, et al. Switching of postmenopausal women with endocrine - responsive early breast cancer to anastrozole after 2 years adjuvant tamoxifen : combined results of ABCSG Trial 8 and ARNO 95 Trial[J]. Lancet,2005,366 (9484) :455 - 462.
10Thurlimann B, Keshaviah A, Coates AS, et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer[ J]. N Engl J Med ,2005,353 (26) :2747 -2757.